Search clinical trials for: Neomune

Total 41 results

Universitas Sriwijaya
M. Djamil General Hospital

Completed

THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL

COVID-19

Indonesia
University of Malaya

Completed

Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury

Traumatic Brain Injury | Nutrient Deficiency | Immuno-Deficiency

Malaysia
Rigshospitalet, Denmark
Odense University Hospital; Zealand University Hospital

Not yet recruiting

Enhancing Referral Decision-making for Advanced Treatment in Parkinson's Disease Through Objective Measurements and Patient Reported Outcomes. (PD-DigiCare)

Parkinson Disease

Denmark
Stanford University

Recruiting

Abdominal Scar Improvement in Microsurgical Breast Reconstruction

Cicatrix | Breast Reconstruction

United States
Neodyne Biosciences, Inc.
U.S. Army Medical Research and Development Command

Completed

A Study of a Novel Silicone Dressing to Minimize Scar Formation (REFINE)

Hypertrophic

United States
Neodyne Biosciences, Inc.

Completed

Investigation of a Novel Silicone Dressing to Maximize the Outcomes of Scar Revision Procedures (IMPROVE) (IMPROVE)

Hypertrophic

United States
Queen's University

Terminated

Uromune in Treating Recurrent Urinary Tract Infections in Women

Recurrent Uti

Canada
Pfizer

Completed

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

Melanoma | Carcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Lymphoma, T-Cell

United States, Germany
Pfizer

Completed

CPG 7909 in Patients With Cutaneous T-Cell Lymphoma

Lymphoma, T-Cell, Cutaneous
Mesoblast, Ltd.

Completed

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy

Spinal Stenosis | Cervical Degenerative Disc Disease | Degenerative Spondylolisthesis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years

Meningococcal Infections | Meningococcal Meningitis

United States
Impatients N.V. trading as myTomorrows
Inmunotek S.L.

No longer available

Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)

Urinary Tract Infections | Bladder Infection | Recurrent Urinary Tract Infection | Urinary Tract Infection Bacterial | Chronic Urinary Tract Infection

Czechia, Denmark, Serbia, France, Germany, Turkey, Belgium, Finland, Luxembourg, Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden
Sanofi Pasteur, a Sanofi Company

Completed

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Meningitis | Neisseria Meningitidis | Meningococcemia

United States
LUTRONIC Corporation

Completed

Efficacy and Safety of Picosecond, Neodymium-doped Yttrium Aluminum Garnet Laser Therapy Using 1,064 nm and 595 nm

Melasma
Ronald Levy
Pfizer

Completed

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

Lymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell

United States
Sanofi Pasteur, a Sanofi Company

Completed

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine

Meningitis | Meningococcal Infections

United States
University of Rochester
Smartfish AS

Completed

Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia

Weight Loss | Lung Cancer | Gastrointestinal Cancer | Cachexia; Cancer

United States
Mesoblast, Ltd.

Completed

Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)

Degenerative Disc Disease | Spinal Stenosis | Spondylolisthesis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age

Meningitis | Meningococcal Infection

United States
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network

Completed

Combination Vaccination Before HIV Treatment Interruption

HIV Infections

Canada
Immune Response BioPharma, Inc.

Unknown

REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study

HIV/AIDS

United States
Mesoblast, Ltd.

Withdrawn

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

Degenerative Disc Disease | Spinal Stenosis | Degenerative Spondylolisthesis

United States
Idorsia Pharmaceuticals Ltd.

Completed

Tezosentan in Acute Heart Failure (VERITAS 1)

Acute Heart Failure | Acute Decompensation of Chronic Heart Failure | New Onset of Heart Failure

United States, United Kingdom, Israel, Switzerland, Austria, Denmark, France, Germany, Greece, Poland
Mesoblast, Ltd.

Completed

Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion

Spinal Stenosis | Cervical Degenerative Disc Disease | Degenerative Spondylolisthesis

Australia
Sanofi

Completed

Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States
Mesoblast, Ltd.

Completed

Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

Degenerative Disc Disease | Spinal Stenosis | Degenerative Spondylolisthesis

United States
NeuroBioPharm Inc.
Neptune Technologies and Bioressources Inc.

Completed

Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE) (MNEMOSYNE)

Early Onset Alzheimer Disease

Canada
Vienna General Hospital

Completed

Neptune Pad ® Compared to Conventional Manual Compression

Postoperative Hemorrhage

Austria
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®

Meningitis | Meningococcal Infections

United States
Immune Response BioPharma, Inc.

Unknown

REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study (RAISE)

HIV

United States
Pfizer

Completed

Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer

Carcinoma, Metastatic Breast

United States
National Institute on Aging (NIA)

Completed

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

Aging

United States
Pfizer

Completed

CPG 7909 Injection in Melanoma

Carcinoma, Melanoma
Pfizer

Completed

CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer

Carcinoma, Breast

United States
GlaxoSmithKline

Completed

Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine

Neisseria Meningitidis | Haemophilus Influenzae Type b

United States
Pfizer

Completed

CPG 7909 Injection in Non-Small Cell Lung Cancer

Carcinoma, Non-Small Cell Lung

United States, Canada, Germany
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older

Meningitis | Meningococcal Infections | Meningococcal Meningitis | Invasive Meningococcal Disease

United States
Sherwood Brown, MD, PhD
University of Miami; University of Texas Rio Grande Valley

Completed

Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders

Bipolar Disorder | Alcohol Use Disorder

United States
University of Memphis

Completed

Health Benefits of a 21-day Daniel Fast

Effects of Krill Oil on Human Health

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Recurrent... and other conditions

United States

Search clinical trials for: Neomune

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations